In a groundbreaking multi-institutional study published in the Journal of Perinatology, researchers have unveiled critical insights into the administration of human milk and breastfeeding practices during the first oral feed for infants diagnosed with critical congenital heart disease (CCHD). This study illuminates how these initial feeding strategies impact the delicate balance of nutrition, immunity, and growth in one of the most vulnerable neonatal populations. The findings present a nuanced understanding that may redefine clinical protocols in neonatal intensive care units worldwide.
Critical congenital heart disease represents a significant subset of congenital malformations, characterized by structural cardiac anomalies that demand urgent intervention within the neonatal period. Infants with CCHD often face profound challenges, not only from the underlying cardiac pathology but also from associated complications such as increased metabolic demands, reduced cardiac output, and the necessity for surgical intervention. Ensuring optimal nutrition during this critical window is paramount, as it has a direct influence on overall morbidity and mortality as well as long-term developmental outcomes.
Traditionally, the initiation of oral feeding in infants with CCHD has been approached with caution. Concerns arise from the risks of necrotizing enterocolitis, feeding intolerance, and aspiration due to compromised hemodynamics and the stress of impending or recent cardiac surgery. However, the benefits of early human milk feeding and breastfeeding—renowned for immunological factors, bioactive components, and optimal nutrition—have prompted a reevaluation of these conservative practices. The challenge lies in balancing these benefits with the clinical vulnerabilities inherent to this patient cohort.
The multi-institutional aspect of this research adds a robust layer of generalizability to the findings. By encompassing a diverse range of neonatal care settings, patient demographics, and institutional feeding protocols, the study mitigates bias introduced by local care variations. This methodical approach ensures that the conclusions drawn are both statistically significant and applicable across disparate healthcare environments, enhancing the overall impact of the research.
Central to the study is the analysis of the first oral feed administered to infants with CCHD—an event that holds both symbolic and clinical importance. This sentinel feeding episode sets the stage for subsequent nutritional planning and may influence patient trajectories during the fragile preoperative or postoperative phases. The researchers meticulously evaluated not only the type of feeding (human milk versus formula) but also the mode (direct breastfeeding versus expressed milk) and the timing in relation to medical and surgical interventions.
One of the most striking revelations of the study is the prevalence and feasibility of providing human milk as the first oral feed among this high-risk group. Despite anticipated logistical and medical barriers, a significant proportion of infants received human milk, with many also engaging in direct breastfeeding. This underscores the emerging paradigm shift towards promoting breastfeeding even in neonates traditionally considered poor candidates due to cardiorespiratory instability or intensive care admission.
The immunological advantages of human milk are well documented, including the provision of secretory IgA, lactoferrin, oligosaccharides, and myriad growth factors. In infants with CCHD, who are inherently susceptible to infections and inflammatory insults, these components may confer protective effects that are particularly vital in the perioperative period. The study’s findings reinforce the clinical relevance of these benefits, highlighting trends toward reduced infectious complications and improved gut integrity in those receiving human milk.
Moreover, the study delves into the physiological mechanisms by which human milk supports the neonate’s system under stress. The bioactive molecules found in human milk modulate inflammatory pathways, enhance intestinal barrier function, and promote the colonization of beneficial microbiota. These effects may be especially critical in infants with CCHD, who often endure prolonged hospital stays, antibiotic exposure, and episodes of hypoperfusion that disrupt gut homeostasis and increase vulnerability to necrotizing enterocolitis.
Breastfeeding, beyond the nutritional component, introduces a psychosocial dimension that further benefits infant outcomes. Skin-to-skin contact and maternal involvement during feeding can attenuate stress responses and promote autonomic stability—factors which are essential in infants whose cardiac physiology is precarious. The study’s emphasis on enabling and encouraging breastfeeding where possible highlights a holistic approach that encompasses emotional and developmental considerations.
From an operational perspective, the study presents data on the barriers to breastfeeding initiation in this population. Factors such as maternal anxiety, clinical instability of the infant, and limitations in lactation support infrastructure are explored. Addressing these challenges requires coordinated multidisciplinary efforts, including specialized nursing training, lactation consultancy, and integration of family-centered care models to optimize feeding experiences and outcomes.
The temporal relationship between the first oral feed and surgical interventions is also scrutinized. The researchers analyze how early feeding practices correlate with timing of cardiac surgeries, noting that early human milk feeding does not appear to increase preoperative risk and may facilitate smoother postoperative recovery. This finding challenges pre-existing clinical dogmas advocating prolonged parenteral nutrition and delayed enteral feeding in CCHD to avoid gastrointestinal complications.
Importantly, the study underscores the role of human milk banks and donor milk supplementation as viable alternatives in cases where maternal milk availability is limited. While direct breastfeeding remains the gold standard, the use of pasteurized donor milk preserves many of the immunologic benefits absent in formula. Institutional policies supporting access to donor milk can thus profoundly influence the nutritional management strategies for these infants.
The methodological rigor of the study includes prospective data collection, standardized feeding protocols, and comprehensive follow-up, ensuring the reliability and depth of the results. Statistical analyses account for confounders such as severity of cardiac defect, gestational age, and comorbidities, reinforcing the validity of conclusions regarding the safety and efficacy of human milk and breastfeeding in this population.
Taken together, this comprehensive investigation invites a paradigm shift in neonatal cardiac care—one that integrates early human milk feeding and breastfeeding as fundamental components of therapeutic strategy rather than adjunctive options to be postponed or avoided. The implications extend beyond immediate neonatal outcomes, potentially influencing neurodevelopment, immune resilience, and quality of life trajectories.
This transformative research not only fills a critical gap in existing literature but also offers actionable insights for clinicians, lactation specialists, and healthcare policymakers. It prompts the reevaluation of feeding protocols and resource allocation to support breastfeeding initiation in neonatal cardiac intensive care units. The ambition is clear: to optimize survival and enhance long-term well-being through evidence-based nutritional interventions attuned to the unique needs of infants with CCHD.
As neonatal care continues to evolve with technological advances and improved surgical techniques, nutritional strategies must keep pace to maximize holistic patient outcomes. The nuanced understanding provided by this study about the role of human milk and breastfeeding at the earliest stages of life in infants with critical congenital heart disease is an indispensable cornerstone upon which future guidelines and care pathways can be constructed.
It is anticipated that the widespread dissemination and integration of these findings will ignite further research exploring the mechanistic underpinnings and long-term effects of human milk feeding in this high-risk group. Moreover, the study sets a precedent for collaborative, multi-institutional efforts to tackle complex clinical questions, paving the way for standardized care models that transcend regional and institutional boundaries.
In summary, Elgersma et al.’s multi-institutional study marks a pivotal advancement in neonatal cardiac nutrition by affirming the safety, feasibility, and clinical advantages of human milk and breastfeeding at the first oral feed for infants with critical congenital heart disease. These insights herald a new era of empathetic, evidence-driven neonatal care where early nutrition transcends sustenance to become a therapeutic linchpin in the fight for fragile newborn lives.
Subject of Research: Human milk and breastfeeding practices at the first oral feed for infants with critical congenital heart disease.
Article Title: Human milk and breastfeeding at the first oral feed for infants with critical congenital heart disease: a multi-institutional study.
Article References:
Elgersma, K.M., Clark, C., Slater, N.L. et al. Human milk and breastfeeding at the first oral feed for infants with critical congenital heart disease: a multi-institutional study. J Perinatol (2026). https://doi.org/10.1038/s41372-026-02724-8
Image Credits: AI Generated
DOI: 10.1038/s41372-026-02724-8 (Published 26 May 2026)
